QUEBEC CITY, Oct. 1 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. , ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its President and CEO, Juergen Engel, Ph.D., will present a corporate overview at BioContact Quebec on Thursday, October 8, 2009, at 2:00 p.m. (eastern) in the Frontenac Room of the Fairmont Chateau Frontenac in Quebec City, Canada.
About AEterna Zentaris Inc.
AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.
CONTACT: Investor Relations: Ginette Vallieres, Investor Relations
Coordinator, (418) 652-8525 ext. 265, gvallieres@aezsinc.com; Media
Relations: Paul Burroughs, Director of Communications, (418) 652-8525 ext.
406, pburroughs@aezsinc.com
